Cargando…
Human Cord Blood for the Hypoxic-Ischemic Neonate
Autologous umbilical cord blood (UCB) is a possible, but unproven, treatment for acute neonatal brain damage. Mesenchymal stem cells (MSC), which are present in UCB, are likely to be the treating cell type. UCB are effective in the treatment of neonatal rodent hypoxic-ischemic injury (HI) and other...
Autor principal: | Carroll, James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640287/ https://www.ncbi.nlm.nih.gov/pubmed/22278181 http://dx.doi.org/10.1038/pr.2011.53 |
Ejemplares similares
-
Rat umbilical cord blood cells attenuate hypoxic–ischemic brain injury in neonatal rats
por: Nakanishi, Keiko, et al.
Publicado: (2017) -
Umbilical cord blood therapy modulates neonatal hypoxic ischemic brain injury in both females and males
por: Penny, Tayla R., et al.
Publicado: (2021) -
Peptidomic Analysis of Neonate Umbilical Cord Blood for the Identification of Endogenous Peptides Involved in Hypoxic–Ischemic Encephalopathy
por: Dong, Xiaohua, et al.
Publicado: (2021) -
Umbilical cord blood troponin I, myoglobin and CK-MB in neonatal hypoxic ischemic encephalopathy and the clinical significance
por: Wan, Bin, et al.
Publicado: (2020) -
Diverse actions of cord blood cell therapy for hypoxic‐ischemic encephalopathy
por: Sato, Yoshiaki, et al.
Publicado: (2021)